Conte P - Search Results

1

High-risk early-stage ovarian cancer. Randomized clinical trial comparing cisplatin plus cyclophosphamide versus whole abdominal radiotherapy.

Chiara S, Conte P, Franzone P, Orsatti M, Bruzzone M, Rubagotti A, Odicino F, Rugiati S, Carnino F, Rosso R, et al. Chiara S, et al. Among authors: conte p. Am J Clin Oncol. 1994 Feb;17(1):72-6. doi: 10.1097/00000421-199402000-00016. Am J Clin Oncol. 1994. PMID: 8311013 Clinical Trial.

2

Prognostic factors in node positive primary breast cancer patients treated with adjuvant CMF.

Campora E, Pronzato P, Amoroso D, Bertelli GF, Venturini M, Baldini E, Brunetti I, Sertoli MR, Conte P, Rosso R. Campora E, et al. Among authors: conte p. Anticancer Res. 1992 Sep-Oct;12(5):1555-8. Anticancer Res. 1992. PMID: 1444221

3

Phase II trials of idarubicin, a new anthracycline.

Rosso R, Ardizzoni A, Conte P, Fusco V, Gulisano M, Lionetto R, Pronzato P, Repetto L. Rosso R, et al. Among authors: conte p. Chemioterapia. 1987 Jun;6(2 Suppl):694. Chemioterapia. 1987. PMID: 2855618 No abstract available.

4

Reversal of "atypical"-multidrug resistance by recombinant human tumor necrosis factor in the human ovarian cancer cell line A2780-DX3.

Cimoli G, Valenti M, Parodi S, Mazzoni A, De Sessa F, Conte P, Russo P. Cimoli G, et al. Among authors: conte p. Oncol Res. 1993;5(8):311-23. Oncol Res. 1993. PMID: 8012063

5

Phase II trial of 5-fluorouracil and the natural l isomer of folinic acid in the treatment of advanced colorectal carcinoma.

Rosso R, Mazzei T, Sobrero A, Mini E, Cartei G, Conte P, Labianca R, Cartei F, Falcone A, Pancera G, et al. Rosso R, et al. Among authors: conte p. Eur J Cancer. 1994;30A(3):338-43. doi: 10.1016/0959-8049(94)90253-4. Eur J Cancer. 1994. PMID: 8204356 Clinical Trial.

6

Accelerated epirubicin-ifosfamide-dacarbazine regimen in patients with adult soft tissue sarcomas.

Michelotti A, Romanini A, Giannessi P, Bengala C, Conte P. Michelotti A, et al. Among authors: conte p. Am J Clin Oncol. 1996 Feb;19(1):78-81. doi: 10.1097/00000421-199602000-00016. Am J Clin Oncol. 1996. PMID: 8554042 Clinical Trial.

7

Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer.

Nabholtz JM, Gelmon K, Bontenbal M, Spielmann M, Catimel G, Conte P, Klaassen U, Namer M, Bonneterre J, Fumoleau P, Winograd B. Nabholtz JM, et al. Among authors: conte p. J Clin Oncol. 1996 Jun;14(6):1858-67. doi: 10.1200/JCO.1996.14.6.1858. J Clin Oncol. 1996. PMID: 8656254 Clinical Trial.

8

Filgrastim and lack of support of intensive adjuvant chemotherapy for high-risk breast cancer patients.

Baldini E, Tibaldi C, Lencioni M, Giannessi P, Evangelista G, Roncella M, Spinelli C, Meucci C, da Prato M, Conte P. Baldini E, et al. Among authors: conte p. Am J Clin Oncol. 1997 Apr;20(2):169-72. doi: 10.1097/00000421-199704000-00014. Am J Clin Oncol. 1997. PMID: 9124194 Clinical Trial.

9

Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.

Baldini E, Silvano G, Tibaldi C, Campoccia S, Cionini L, Conte P. Baldini E, et al. Among authors: conte p. Semin Oncol. 2000 Feb;27(1 Suppl 1):28-32. Semin Oncol. 2000. PMID: 10697041 Clinical Trial.

10

Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients.

Michelotti A, Venturini M, Tibaldi C, Bengala C, Gallo L, Carnino F, Del Mastro L, Lionetto R, Montanaro E, Rosso R, Conte P. Michelotti A, et al. Among authors: conte p. Breast Cancer Res Treat. 2000 Jan;59(2):133-9. doi: 10.1023/a:1006394801389. Breast Cancer Res Treat. 2000. PMID: 10817348 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

789 results

Search Page

Filters